Globus Medical, Inc

Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures. It combines implantable devices, biologics, surgical instruments and enabling technologies such as robotics and navigation to help surgeons perform procedures more efficiently and reproducibly.

25,7 %

67,4 %

18,3 %

+16,7 %

4.26

2.74

— Globus Medical, Inc
%
Musculoskeletal Solutions85% Implantable devices, biologics, accessories, unique surgical instruments, neuromonitoring and stimulation products used in spine and orthopedic procedures.
Enabling Technologies15% Advanced hardware, software and related technologies that improve surgical precision, workflow and reproducibility.

Globus sells primarily to hospitals, ambulatory surgery centers and physicians that perform musculoskeletal procedures...

  • Hospitalsprimary

    Buy implant sets, instruments, biologics and enabling technologies for inpatient and outpatient musculoskeletal procedures.

  • Ambulatory surgery centersprimary

    Buy procedure-ready systems and technologies that support faster, more efficient outpatient surgery.

  • Physicians and surgeonsprimary

    Influence product selection and buy or specify surgeon-preferred implants, tools and navigation systems.

  • International distributorssecondary

    Sell and support Globus products in non-U.S. markets where direct coverage is not used.

Globus is headquartered in Audubon, Pennsylvania and operates globally, with sales presence in 65 countries worldwide...

  • •Headquartered in Audubon, Pennsylvania, United States
  • •U.S. is the largest revenue market and sales-force focus
  • •International sales presence spans 64 countries outside the U.S.
  • •Operations and commercialization extend across 65 countries worldwide
  • •Europe, Middle East, Asia Pacific and Latin America drive non-U.S. growth

Globus is focused on expanding its U.S. sales force, deepening penetration in existing territories and broadening...

01
Expand U.S. sales force and territory coverageshort-term

More reps and broader coverage should increase procedure adoption and deepen account penetration.

02
International expansionmedium-term

Broader non-U.S. commercialization diversifies revenue and extends the installed base for products and technologies.

03
Selective acquisitions and alliancesmedium-term

Acquisitions can add technology, personnel and market access that accelerate growth and product breadth.

04
Product innovation and launchesshort-term

Frequent launches support surgeon adoption and help defend share in a competitive device market.

Globus faces execution risk from integrating acquisitions, maintaining surgeon and hospital adoption, and managing a...

high

Acquisition integration risk

The company has grown through acquisitions and may not realize expected synergies or product benefits.

Scope
NuVasive, Nevro and other acquired businesses
Materiality
high
high

Competitive adoption risk

Revenue depends on convincing surgeons and hospitals that Globus systems are preferable to alternatives.

Scope
Spine, orthopedic and neurosurgical procedure markets
Materiality
high
high

Regulatory and compliance risk

Medical device marketing, manufacturing and biologics activities are subject to FDA and fraud-and-abuse rules.

Scope
U.S. and foreign regulatory regimes
Materiality
high
medium

Tariff and supply-chain disruption

Tariffs or countermeasures can increase input costs and disrupt global sourcing and distribution.

Scope
International supply chain and third-party suppliers
Materiality
high
medium

Foreign exchange and international operations

Non-U.S. revenue and costs create translation and transaction exposure.

Scope
Europe, Middle East, Asia Pacific and Latin America
Materiality
medium
Revenue recognition timing
Can shift revenue between quarters and affect comparability
Goodwill and intangible impairment
Potential non-cash impairment charges
Acquisition accounting and bargain purchase gain
Can create volatile non-operating gains
Inventory and excess/obsolete reserves
Affects cost of sales and gross margin
Foreign currency translation
Can move other income/expense and net income

GLOBUS MEDICAL INC

GMED · Surgical & Medical Instruments & Apparatus

Modular Medical, Inc.

MODD · Surgical & Medical Instruments & Apparatus

Profusa, Inc.

PFSA · Surgical & Medical Instruments & Apparatus

InspireMD, Inc.

NSPR · Surgical & Medical Instruments & Apparatus

Corbus Pharmaceuticals Holdings, Inc.

CRBP · Pharmaceutical Preparations

GLOBE LIFE INC.

GL · Life Insurance

: 28/04/2026